Bacteriologically confirmed extra pulmonary tuberculosis and treatment outcome of patients consulted and treated under program conditions in the littoral region of Cameroon

• Published in: BMC pulmonary medicine 2019-01, Vol.19 (1), p.17-17, Article 17
• Main Authors: Mbuh, Teyim Pride, Ane-Anyangwe, Irene, Adeline, Wandji, Thumamo Pokam, Benjamin D, Meriki, Henry Dilonga, Mbacham, Wilfred Fon
• Format: Article
• Language: English
• Subjects: Abdomen; Acquired immune deficiency syndrome; AIDS; Care and treatment; Clinical outcomes; Diagnosis; Epidemiology; Extra pulmonary TB; Gene xpert MTB/RIF; Genetic research; HIV; HIV infections; HIV patients; Human immunodeficiency virus; Infections; Laboratories; Littoral region Cameroon; Lungs; Lymph nodes; Lymphatic system; Males; Patient outcomes; Patients; Pleural cavity; Pulmonary tuberculosis; Pulmonology; Rifampin; Statistics; Studies; Success; Systematic review; Treatment outcome; Tuberculosis
• ISSN: 1471-2466; 1471-2466
• DOI: 10.1186/s12890-018-0770-x

Extra-pulmonary tuberculosis (EPTB) is defined as any bacteriologically confirmed or clinically diagnosed case of TB involving organs other than the lungs. It is frequently a diagnostic and therapeutic challenge with paucity of data available. The aim of this study was to assess the prevalence of bacteriologically confirmed EPTB; to determine the most affected organs and to evaluate the therapeutic outcome of EPTB patients treated under program conditions in the littoral region of Cameroon. A descriptive cross-sectional laboratory-based epidemiological survey was conducted from January 2016 to December 2017 and 109 specimens from 15 of the 39 diagnosis and treatment centers in the littoral region were obtained. Two diagnostic methods (Gene Xpert MTB and culture (LJ and MGIT) were used for EPTB diagnosis. Determine HIV1/2 and SD Biolinewere used for HIV diagnosis. Confirmed EPTB cases were treated following the national tuberculosis guide. The prevalence of bacteriologically confirmed EPTB was 41.3% (45). All 45 cases were sensitive to rifampicin. Males were predominately more infected [26 (57.8%)] likewise the age group 31-45 years with 15 (33.3%) cases. The overall prevalence for HIV was 33.6% (36). HIV infection was present in 28.9% (13) of patients with EPTB. The most affected sites with EPTB were: Lymph nodes (66.5%), pleural cavity (15.6%), abdominal organs (11.1%), neuromeningeal (2.2%), joints (2.2%) and heart (2.2%). Overall, 84.4% of the study participants had a therapeutic success with males responding better 57.9% (p = 0.442). Therapeutic success was better (71.7%) in HIV negative EPTB patients (p = 0.787). The prevalence of bacteriologically confirmed EPTB patients treated under program conditions in the littoral region of Cameroon is high with a therapeutic success of 84.4% and the lymph nodes is the most affected site.